High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

✍ Scribed by van der Velden, V H J; Boeckx, N; Jedema, I; te Marvelde, J G; Hoogeveen, P G; Boogaerts, M; van Dongen, J J M

• Book ID: 110055876
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 185 KB
• Volume: 18
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2403350